AbbVie
ABBV
#34
Rank
$283.57 B
Marketcap
$160.58
Share price
-1.44%
Change (1 day)
10.82%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2023 (TTM): $6.25 B

According to AbbVie's latest financial reports the company's current earnings (TTM) are $6.25 B. In 2022 the company made an earning of $13.47 B an increase over its 2021 earnings that were of $12.98 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) $6.25 B-53.62%
2022 $13.47 B3.76%
2021 $12.98 B282.25%
2020 $3.39 B-59.67%
2019 $8.42 B62.13%
2018 $5.19 B-32.74%
2017 $7.72 B-1.99%
2016 $7.88 B18.65%
2015 $6.64 B180.5%
2014 $2.36 B-55.57%
2013 $5.33 B-6.86%
2012 $5.72 B56.05%
2011 $3.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$3.26 B-47.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.56 B 20.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.85 B 25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.32 B-78.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.85 B 9.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.85 B-193.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.08 B 45.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$6.88 B 10.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.47 B-92.40%๐Ÿ‡บ๐Ÿ‡ธ USA